Search Results - "Liu, Luna"

Refine Results
  1. 1

    Risk factors for early readmission to hospital in patients with malignancy-related ascites: a retrospective cohort study by Tian, Zhenhua, Huang, Zhilong, Guo, Yaqi, Zhao, Xiaolin, Liu, Luna, Yu, Chunxiao, Guan, Qingbo

    Published in Frontiers in oncology (01-10-2024)
    “…Malignancy-related ascites (MRA) is a common serious complication of many advanced malignant tumors with high morbidity and mortality. The high hospital…”
    Get full text
    Journal Article
  2. 2

    Association of Obesity based on Different Metabolic Status with Risk of Gout Occurrence in Patients: A National Study by Wang, Yanyan, Liu, Luna, Ma, Shizhan, Han, Junming, Wang, Zhixiang, Fan, Xiude, Hou, Xu

    “…Obesity often co-exists with metabolic abnormalities, but the results of studies on the relationship between obesity, metabolic abnormalities and the risk of…”
    Get more information
    Journal Article
  3. 3

    Characterization of intact antibody–drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography–mass spectrometry by Xu, Keyang, Liu, Luna, Saad, Ola M., Baudys, Jakub, Williams, Lara, Leipold, Douglas, Shen, Ben, Raab, Helga, Junutula, Jagath R., Kim, Amy, Kaur, Surinder

    Published in Analytical biochemistry (01-05-2011)
    “…Antibody–drug conjugates (ADCs) are designed to facilitate the targeted delivery of cytotoxic drugs to improve their tumor fighting effects and minimize…”
    Get full text
    Journal Article
  4. 4

    Evaluating the Impact of Obesity and Different Metabolic Statuses on the Prognosis of Hospitalized Patients with Inflammatory Bowel Disease: A Cohort Study by Wang, Yanyan, Liu, Luna, Han, Junming, Fan, Xiude, Guo, Qingling, Wu, Zhongming

    Published in Obesity facts (08-08-2023)
    “…Introduction: Obesity is associated with an increased risk of inflammatory bowel disease (IBD), whereas not all obese individuals have the same effect. In…”
    Get full text
    Journal Article
  5. 5

    The health-care utilization and economic burden in patients with genetic skeletal disorders by Liu, Luna, Shi, Yingzhou, Fan, Xiude, Yao, Yangyang, Wu, Wanhong, Tian, Yang, Wu, Huixiao, Li, Zongyue, Wang, Yanzhou, Xu, Chao

    Published in Orphanet journal of rare diseases (04-03-2024)
    “…Most genetic skeletal disorders (GSD) were complex, disabling and life-threatening without effective diagnostic and treatment methods. However, its impacts on…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Correlation Between Gut Microbiota and Testosterone in Male Patients With Type 2 Diabetes Mellitus by Liu, Shuang, Cao, Ruying, Liu, Luna, Lv, Youyuan, Qi, Xiangyu, Yuan, Zhongshang, Fan, Xiude, Yu, Chunxiao, Guan, Qingbo

    Published in Frontiers in endocrinology (Lausanne) (25-03-2022)
    “…This study aimed at investigating the association between testosterone levels and gut microbiota in male patients with type 2 diabetes mellitus (T2DM) and…”
    Get full text
    Journal Article
  8. 8

    Signal peptidase 21 suppresses cell proliferation, migration, and invasion via the PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma by Zhang, Na, Cao, Shiguang, Sun, Ruiying, Wang, Yibei, Liu, Luna, Wang, Wei, Meng, Xia

    Published in PeerJ (San Francisco, CA) (17-10-2022)
    “…In a previous study, a total of 568 differentially expressed proteins including the signal peptidase SPC21 were identified from lung adenocarcinoma (LUAD) and…”
    Get full text
    Journal Article
  9. 9

    The Fatty Liver Index, the Strongest Risk Factor for Low Testosterone Level by Liu, Luna, Li, Man, Chen, Pengcheng, Li, Yuchen, Song, Qianmei, Han, Junming, Fang, Li, Guan, Qingbo, Yu, Chunxiao

    Published in Obesity facts (01-12-2023)
    “…Abstract Introduction: The study aimed to determine if hepatic steatosis assessed by fatty liver index (FLI) was an independent risk factor for male low…”
    Get full text
    Journal Article
  10. 10

    The impact of metabolic overweight/obesity phenotypes on unplanned readmission risk in patients with COPD: a retrospective cohort study by Tian, Yang, Liu, Luna, Li, Yuchen, Fan, Xiude, Wu, Wanhong, Shi, Yingzhou, Jiang, Jie, Yuan, Zinuo, Dong, Hang, Li, Huijie, Xuan, Qiuhui, Xu, Chao

    Published in Frontiers in physiology (28-11-2023)
    “…There is an inconsistent association between overweight/obesity and chronic obstructive pulmonary disease (COPD). Considering that different metabolic…”
    Get full text
    Journal Article
  11. 11

    A multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study by Xu, Keyang, Liu, Luna, Maia, Mauricio, Li, Jenny, Lowe, John, Song, An, Kaur, Surinder

    Published in Bioanalysis (01-01-2014)
    “…Combination therapies with monoclonal antibodies (mAbs) enhance therapeutic activity and may circumvent drug resistance. However, these studies present…”
    Get full text
    Journal Article
  12. 12

    The Predictability of Cystatin C for Peripheral Arterial Disease in Chinese Population with Type 2 Diabetes Mellitus by Liu, Luna, Wang, Hai, Ning, Jing, Han, Junming, Yu, Chunxiao, Guan, Qingbo

    Published in Journal of diabetes research (29-03-2022)
    “…Objectives. Peripheral artery disease (PAD) in diabetic populations is a vital chronic disease all over the world due to its high morbidity and mortality. It…”
    Get full text
    Journal Article
  13. 13

    Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets by Shi, Yingzhou, Dong, Hang, Sun, Shiwei, Wu, Xiaoqin, Fang, Jiansong, Zhao, Jianbo, Han, Junming, Li, Zongyue, Wu, Huixiao, Liu, Luna, Wu, Wanhong, Tian, Yang, Yuan, Guandou, Fan, Xiude, Xu, Chao

    Published in Clinical and molecular hepatology (01-01-2024)
    “…To evaluate the causal correlation between complement components and non-viral liver diseases and their potential use as druggable targets. We conducted…”
    Get full text
    Journal Article
  14. 14

    Effects of increasing intake of soybean oil on synthesis of testosterone in Leydig cells by Su, Yu, Tian, Zhenhua, Qi, Xiangyu, Luo, Dandan, Liu, Luna, Liu, Shuang, Zheng, Dongmei, Wei, Fang, He, Zhao, Guan, Qingbo

    Published in Nutrition & metabolism (26-05-2021)
    “…Abstract Background Soybean oil is a very common edible oil in daily life. With the changes in the dietary composition, the intake of soybean oil increased…”
    Get full text
    Journal Article
  15. 15

    Metformin inhibits inflammatory response and endoplasmic reticulum stress to improve hypothalamic aging in obese mice by Yang, Leilei, Lu, Peng, Qi, Xiangyu, Yang, Qian, Liu, Luna, Dou, Tao, Guan, Qingbo, Yu, Chunxiao

    Published in iScience (20-10-2023)
    “…The hypothalamus, as a vital brain region for endocrine and metabolism regulation, undergoes functional disruption during obesity.The anti-aging effect of…”
    Get full text
    Journal Article
  16. 16

    Dominant-negative HNF1α mutant promotes liver steatosis and inflammation by regulating hepatic complement factor D by Liu, Moke, Liu, Luna, Guo, Honglin, Fan, Xiude, Liu, Tianbao, Xu, Chao, He, Zhao, Song, Yongfeng, Gao, Ling, Shao, Shanshan, Zhao, Jiajun, Lu, Peng

    Published in iScience (20-10-2023)
    “…Patients with HNF1A variants may develop liver steatosis, while the underlying mechanism is still unclear. Here, we established a mouse model carrying the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    How Different Institutional Logics Affect the Female CEO Gender Effect on IPO Underpricing in China by Liu, Yu Luna, Park, Haemin Dennis, Velamuri, S. Ramakrishna

    Published in Entrepreneurship theory and practice (01-03-2024)
    “…Female entrepreneurs and CEOs generally face greater challenges in securing funding to exploit entrepreneurial opportunities, yet contextual factors under…”
    Get full text
    Journal Article
  19. 19

    Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case study by Peng, Kun, Xu, Keyang, Liu, Luna, Hendricks, Robert, Delarosa, Reginald, Erickson, Rich, Budha, Nageshwar, Leabman, Maya, Song, An, Kaur, Surinder, Fischer, Saloumeh K

    Published in mAbs (02-11-2014)
    “…RG7652 is a human immunoglobulin 1 (IgG1) monoclonal antibody (mAb) targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) and is designed for the…”
    Get full text
    Journal Article
  20. 20

    High Levels of HER-2 Expression Alter the Ability of Epidermal Growth Factor Receptor (EGFR) Family Tyrosine Kinase Inhibitors to Inhibit EGFR Phosphorylation in Vivo by CHRISTENSEN, James G, SCHRECK, Randall E, MENDEL, Dirk B, CHAN, Emily, XUEYAN WANG, YANG, Chris, LUNA LIU, CUI, Jean, LI SUN, WEI, James, CHERRINGTON, Julie M

    Published in Clinical cancer research (01-12-2001)
    “…The epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases have been implicated in the development, progression, and severity of several human…”
    Get full text
    Journal Article